TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management

Documenti analoghi

• Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases
  di: Saubia Fathima, et al.
  Pubblicazione: (2025)
• Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
  di: Shai Shimony, et al.
  Pubblicazione: (2025)
• Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management
  di: Jorge J. Castillo, et al.
  Pubblicazione: (2026)
• Outcomes of Post‐Transplant Rh‐ GCSF and Decitabine Maintenance Therapy in Patients With High‐Risk Myeloid Neoplasm
  di: Mathias Palmer, et al.
  Pubblicazione: (2025)
• Erratum to: “Cutaneous T‐Cell Lymphomas: 2023 Update on Diagnosis, Risk‐Stratification, and Management”
  Pubblicazione: (2025)